New Analyses Support Infliximab Use for Severe Psoriasis, Show ... - DG News
February 5, 2007| New Analyses Support Infliximab Use for Severe Psoriasis, Show ... DG News - Treatment efficacy after 10 weeks of treatment was evaluated using the Psoriasis Area Severity Index 75 (PASI 75), which determined 75% or greater ... REMICADE(R) Therapy Shown To Improve Productivity In Patients ... Firms tout study results at dermatology conference |
Scientist to study clotting disorder APS - Science Daily (press release)
February 5, 2007| Scientist to study clotting disorder APS Science Daily (press release) - Rheumatoid arthritis -- Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disorder that causes the immune system to attack the joints. ... |
ANGEL THOUGHTS - Manila Bulletin
February 5, 2007| ANGEL THOUGHTS Manila Bulletin, Philippines - Salido said that a group of Swedish rheumatologists described the effects of cigarette smoking on the development of rheumatoid arthritis (RA) and systemic ... |
Psoriasis Patients Show Significant Improvement in Symptoms with ... - Drug Newswire (press release)
February 5, 2007| Psoriasis Patients Show Significant Improvement in Symptoms with ... Drug Newswire (press release), CT - HUMIRA is the only fully human monoclonal antibody approved for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing ... |
Funding can depend on where you live - ic Wales
February 5, 2007| Funding can depend on where you live ic Wales, UK - Rituximab for rheumatoid arthritis. One patient has received funding at a cost of £15000 for a year of treatment. Herceptin (via the North Wales risk ... |